Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naïve chronic hepatitis B patients in Japan

被引：0
|
作者：
Fumitaka Suzuki
Tetsuya Hosaka
Yoshiyuki Suzuki
Hitomi Sezaki
Norio Akuta
Shunichiro Fujiyama
Yusuke Kawamura
Masahiro Kobayashi
Satoshi Saitoh
Yasuji Arase
Kenji Ikeda
Mariko Kobayashi
Rie Mineta
Yukiko Suzuki
Hiromitsu Kumada
机构：
[1] Toranomon Hospital,Department of Hepatology
[2] Okinaka Memorial Institute for Medical Research,Research Institute for Hepatology
[3] Toranomon Branch Hospital,undefined
来源：
Journal of Gastroenterology | 2019年 / 54卷
关键词：
Hepatitis B virus; Entecavir; HBsAg seroclearance; Resistance; Viral breakthrough;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：182 / 193
页数：11
相关论文
共 50 条
  • [31] Efficacy of 3 years of continuous entecavir treatment in nucleos(t)ide-naive chronic hepatitis B patients
    Mai, Li
    Yan, Ying
    Yang, Ling
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 920 - 920
  • [32] Entecavir plus tenofovir combination therapy for chronic hepatitis B in patients with previous nucleos(t)ide treatment failure
    Zoulim, Fabien
    Bialkowska-Warzecha, Jolanta
    Diculescu, Mircea Mihai
    Goldis, Adrian Eugen
    Heyne, Renate
    Mach, Tomasz
    Marcellin, Patrick
    Petersen, Joerg
    Simon, Krzysztof
    Bendahmane, Soumaya
    Klauck, Isabelle
    Wasiak, Wojciech
    Janssen, Harry L. A.
    HEPATOLOGY INTERNATIONAL, 2016, 10 (05) : 779 - 788
  • [33] Long-term results of chronic hepatitis B antiviral treatment with nucleos(t)ide analogues: a single center experience
    Caviglia, Gian P.
    Olivero, Antonella
    Ngatchou, Doriane
    Saracco, Giorgio M.
    Smedile, Antonina
    MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2019, 65 (01) : 77 - 78
  • [34] Efficacy of Entecavir Treatment for up to 5 Years in Nucleos(t)ide-Naive Chronic Hepatitis B Patients in Real Life
    Luo, Jie
    Li, Xiangyong
    Wu, Yuankai
    Lin, Guoli
    Pang, Yihua
    Zhang, Xiao
    Ao, Yunlong
    Du, Zhan
    Zhao, Zhixin
    Chong, Yutian
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (04): : 427 - 433
  • [35] Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis B
    Lee, I-Cheng
    Sun, Cheuk-Kay
    Su, Chien-Wei
    Wang, Yuan-Jen
    Chang, Hung-Chuen
    Huang, Hui-Chun
    Lee, Kuei-Chuan
    Huang, Yi-Shin
    Perng, Chin-Lin
    Liu, Yuh-Hwa
    Chua, Chian-Sem
    Lin, Yu-Min
    Lin, Han-Chieh
    Huang, Yi-Hsiang
    MEDICINE, 2015, 94 (32)
  • [36] Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapy
    Franze, Maria Stella
    Saitta, Carlo
    Lombardo, Daniele
    Musolino, Cristina
    Caccamo, Gaia
    Filomia, Roberto
    Pitrone, Concetta
    Cacciola, Irene
    Pollicino, Teresa
    Raimondo, Giovanni
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2025, 49 (04)
  • [37] Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B
    Ogawa, Eiichi
    Nomura, Hideyuki
    Nakamuta, Makoto
    Furusyo, Norihiro
    Koyanagi, Toshimasa
    Dohmen, Kazufumi
    Ooho, Aritsune
    Satoh, Takeaki
    Kawano, Akira
    Kajiwara, Eiji
    Takahashi, Kazuhiro
    Azuma, Koichi
    Kato, Masaki
    Shimoda, Shinji
    Hayashi, Jun
    LIVER INTERNATIONAL, 2020, 40 (07) : 1578 - 1589
  • [38] Long-term hepatitis B surface antigen kinetics after nucleos(t)ide analog discontinuation in patients with noncirrhotic chronic hepatitis B
    Wu, Lina
    Lai, Jiadi
    Luo, Qiumin
    Zhang, Yeqiong
    Lin, Chaoshuang
    Xie, Dongying
    Chen, Youming
    Deng, Hong
    Gao, Zhiliang
    Peng, Liang
    Xu, Wenxiong
    LIVER RESEARCH, 2024, 8 (03) : 179 - 187
  • [39] Antiviral effect of entecavir in chronic hepatitis B: Influence of prior exposure to nucleos(t)ide analogues
    Reijnders, Jurrien G. P.
    Deterding, Katja
    Petersen, Joerg
    Zoulim, Fabien
    Santantonio, Teresa
    Buti, Maria
    van Boemmel, Florian
    Hansen, Bettina E.
    Wedemeyer, Heiner
    Janssen, Harry L. A.
    JOURNAL OF HEPATOLOGY, 2010, 52 (04) : 493 - 500
  • [40] Combination of pegylated interferon-alpha and nucleos(t)ide analogue treatment enhances the activity of natural killer cells in nucleos(t)ide analogue experienced chronic hepatitis B patients
    Pang, X.
    Zhang, L.
    Liu, N.
    Liu, B.
    Chen, Z.
    Li, H.
    Chen, M.
    Peng, M.
    Ren, H.
    Hu, P.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2020, 202 (01): : 80 - 92
12345